phloretin has been researched along with Bone Cancer in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteosarcoma is the most common primary malignancy of bone." | 1.40 | Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells. ( Fu, WM; Hsieh, IS; Yang, RS, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogawa, T | 1 |
| Sasaki, A | 1 |
| Ono, K | 1 |
| Ohshika, S | 1 |
| Ishibashi, Y | 1 |
| Yamada, K | 1 |
| Hsieh, IS | 1 |
| Yang, RS | 1 |
| Fu, WM | 1 |
2 other studies available for phloretin and Bone Cancer
| Article | Year |
|---|---|
Uptake of fluorescent D- and L-glucose analogues, 2-NBDG and 2-NBDLG, into human osteosarcoma U2OS cells in a phloretin-inhibitable manner.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Bone Neoplasms; Cytochalasin B; Deoxyglucose; Depression, Che | 2021 |
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Daunorubicin; Etoposide; Fluorouracil; Gluc | 2014 |